In support of this concept, Koumangoye et al. demonstrated that reduced AnxA6 expression was associated with poor overall and distant metastasis-free survival of basal-like breast cancer patients and moreover, sensitized TNBC cells to TKIs [29]. This evidence concerns the gene ANXA6 and breast carcinoma.